Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 5,998

Document Document Title
WO/2010/019547A1
Disclosed herein are cannabinoid receptor ligands of formula (I), wherein Y, X1, X2, X3, R1, and R2 are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such...  
WO/2010/014666A2
The present invention includes methods/processes and intermediates for preparing compounds having structural Formula (I): (I), wherein X is alkyl, substituted alkyl, alkenyl, substituted alkenyl, heteroalkyl, substituted heteroalkyl, het...  
WO/2010/012795A1
The present invention relates to fungicide N-(2-phenoxyethyl)carboxamide derivatives of formula (I), their aza, thia and sila analogues, their process of preparation, their use as fungicides, particularly in the form of fungicidal compos...  
WO/2009/129267A3
Pleckstrin homology domain binding compounds, pharmaceutical compositions including such compounds, and methods for their use are described herein.  
WO/2010/010133A1
The present invention relates to sultam compounds, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in treating disorders mediated by GlyT1, including neurological and neuropsy...  
WO/2010/008081A1
Disclosed is an azo pigment which has excellent color characteristics such as coloring power and hue, while exhibiting excellent durability such as light resistance. A pigment dispersion is also disclosed. Specifically disclosed is an a...  
WO/2010/006938A1
The invention is concerned with novel heterocyclyl compounds of formula (I); wherein A, X, Y1, Y2, Y3, R3, R4, R5, R6, R7, R8, R9, R10, m, n and p are as defined in the description and in the claims, as well as physiologically acceptable...  
WO/2010/005782A1
Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally use...  
WO/2010/004139A1
Compounds of formula (I) in which Rcy represents a cycloalkyl group or an unsubstituted or substituted cycloalkylalkyl group, R1, R2, R3 and R4, which are identical or different, each represent a hydrogen or halogen atom or a group nitro...  
WO/2009/117421A3
The present invention relates to compounds and methods which may be useful as inhibitors of GPR119 for the treatment or prevention of metabolic, cardiovascular, and metabolic diseases.  
WO/2009/156098A2
The invention relates to thiadiazolyloxyphenylamidines of general formula (I), to a method for the production thereof, to the use of the claimed amidines for the control of undesired microorganisms, and to an agent for said purpose compr...  
WO/2009/156074A2
The invention relates to thiadiazolyloxyphenylamidines of general formula (I), to a method for the production thereof, to the use of the claimed amidines for the control of undesired microorganisms, and to an agent for said purpose compr...  
WO/2009/150497A1
The present invention relates to an improved process for the preparation of Hydrochlorothiazide of formula (I) having purity of at least 99.9% and OVI content below detectable limit. The present invention further provides a new polymorph...  
WO/2009/150248A1
The present invention relates to a compound of general formula (I) : and also to the pharmaceutically acceptable salts thereof, to the isomers or isomer mixtures thereof in all proportions, in particular to an enantiomer mixture, and esp...  
WO/2009/119980A3
The present invention relates to novel benzophenone thiazole derivatives of chemical formula 1, isomers thereof, pharmaceutically acceptable salts thereof, hydrates thereof or solvates thereof, pharmaceutical compositions containing the ...  
WO/2009/101082A9
The present invention relates to the use of substituted sulfonic acid amide compounds of formula I, wherein Ra, n, Het, A, Y and D are as defined in the claims and the N-oxides and the salts thereof for combating phytopathogenic harmful ...  
WO/2009/148719A1
The use of N-formamidino-5-amino-3H-1,2,4-dithiazole-3-thiones as novel, efficient sulfur-transfer reagents is disclosed. The sulfur transfer from these reagents to compounds containing P(III) atom, triphenylphosphine, 5'-O-DMT-thymidine...  
WO/2009/069132A3
Compounds that are capable of inhibiting an activity of a reverse transcriptase are disclosed. Further disclosed are pharmaceutical compositions containing these compounds, and methods of inhibiting an activity of reverse transcriptase a...  
WO/2009/135526A1
Substituted amides of the general formula (I): with the residues A, R1 and R2 as explained in detail in the description are described. The compounds are suitable in particular as neutral endopeptidase inhibitors and are highly potent.  
WO/2009/095098A3
The present invention relates to the use of compounds according to general formula (I) particularly benzothiadiazoles as a protection against the effects of abiotic stress on plants.  
WO/2009/133687A1
Disclosed is a compound having an anti-hyperglycemic activity, which is useful for the treatment or prevention of diabetes, obesity and others. Specifically disclosed is a compound represented by general formula (1) [wherein R1 and R2 in...  
WO/2009/134616A2
The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a...  
WO/2009/134110A1
Invention is related to novel compounds - 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles with general formula (I). The compounds can be used in biomedicine as active ingredients in pharmaceutical formulations, because th...  
WO/2009/108720A3
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antag...  
WO/2009/129939A2
Disclosed is the use of 5-amino-1,2,4-thiadiazole, the salts, metal complexes, and simple derivatives thereof according to formulas (I) and (II) as a substance for inhibiting or controlling nitrification.  
WO/2008/128639A8
The present invention relates to thiadiazolyl oxyphenyl amidines of the general formula (I), a method for the production thereof, the use of the amidines according to the invention for the control of undesired microorganisms, and an agen...  
WO/2009/105214A3
This invention provides compounds of formulas H, Ia, H, and or salts thereof, pharmaceutical compositions comprising a compound of formulas H, Ia, H and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor...  
WO/2009/123316A1
Disclosed is an sGC activator, particularly a compound which is useful for the prevention or treatment of diseases including hypertension, ischemic heart diseases, heart failure, kidney diseases, arteriosclerotic diseases, atrial fibrill...  
WO/2009/102893A3
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antag...  
WO/2009/123164A1
Disclosed is a compound useful as an endothelial lipase inhibitor. Specifically disclosed is a compound represented by the formula, a pharmaceutically acceptable salt thereof, or a solvate of the compound or the pharmaceutically acceptab...  
WO/2009/108720A2
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antag...  
WO/2009/106817A2
There is provided a compound of formula R1-CO-X-Y-Z-R2 wherein X and Z are each optional groups independently selected from saturated or unsaturated carbon chains having a length of 1 to 3 carbons; Y is SO, S, SO2, CH=CH, CH2CH2 or O; R1...  
WO/2009/105214A2
This invention provides compounds of formulas H, Ia, H, and or salts thereof, pharmaceutical compositions comprising a compound of formulas H, Ia, H and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor...  
WO/2009/101082A1
The present invention relates to the use of substituted sulfonic acid amide compounds of formula I, wherein Ra, n, Het, A, Y and D are as defined in the claims and the N-oxides and the salts thereof for combating phytopathogenic harmful ...  
WO/2009/102893A2
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antag...  
WO/2009/095098A2
The present invention relates to the use of compounds according to general formula (I) particularly benzothiadiazoles as a protection against the effects of abiotic stress on plants.  
WO/2009/096039A1
A compound useful as an intermediate for obtaining a thiadiazole-based acaricide having a high purity in a high yield. This intermediate is obtained, for example, by reacting a 2-(4-hydroxyphenoxy)propionic acid ester represented by the ...  
WO/2009/067600A3
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory di...  
WO/2009/086277A1
Tetrasubstituted benzenes that act as modulators of gamma secretase and their use in the treatment of one or more symptoms of treating neurodegenerative disorders, e.g., Alzheimer's disease, are described.  
WO/2009/083105A1
The present invention relates to thiazolyloxyphenylamidines or thiadiazolyloxyphenylamidines of the general formula (I), a process for preparing them, the use of the amidines according to the invention for the control of undesirable micr...  
WO/2009/081789A1
A compound that is useful as an agent in the prevention and treatment of circulatory system, nervous system, metabolic, reproductive system, and gastrointestinal diseases. Formula (I) is a compound represented by the following: [structur...  
WO/2009/078498A1
A novel biarylpyrazole 4-carboxamide compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor ligand, which is useful for preventing or treating obesity and obesity-related metaboli...  
WO/2009/079593A1
The present invention is directed to piperidinyl and piperazinyl derivatives of formula (I) useful as inhibitors of the NPY Y2 receptor, pharmaceutical compositions comprising said compounds, processes for the preparation of said compoun...  
WO/2009/075080A1
Disclosed is a fluoroalkylsulfide derivative having excellent pest control activity or a salt thereof. Also disclosed is a pest control agent characterized by containing such a fluoroalkylsulfide derivative or a salt thereof as an active...  
WO/2009/076502A1
The present invention is directed to processes for the preparation of hydroxy-substituted aryl sulfamide derivatives of the formula I or pharmaceutically acceptable salts, stereoisomers or tautomers thereof, which are monoamine reuptake ...  
WO/2008/110278A3
The use of N2-phenylamidines of general formula (I) as herbicides is disclosed. In said general formula (I) R2, R3, R4, R5 and R6 are various groups and A is a bond or various single- or multi-atom bridge elements.  
WO/2009/069132A2
Compounds that are capable of inhibiting an activity of a reverse transcriptase are disclosed. Further disclosed are pharmaceutical compositions containing these compounds, and methods of inhibiting an activity of reverse transcriptase a...  
WO/2009/049180A3
The present invention relates to compounds of formula I'' useful as inhibitors of voltage -gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods ...  
WO/2009/067600A2
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory di...  
WO/2009/067621A1
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory di...  

Matches 351 - 400 out of 5,998